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Introduction: Ultrasound therapy promotes cytokine release in vitro1 and has been suggested to 
improve the healing rates of pressure ulcers2. Unfortunately much of the evidence is conflicting, 
and it is difficult to draw firm conclusions on effectiveness3.  Traditionally US is thought to 
promote the release of proinflammatory cytokines and speed up the inflammatory phase of tissue 
repair5. Thus the aim of this study was to investigate the effect of US on proinflammatory cytokine 
release in vivo. 
Methods: Fifteen healthy volunteers were recruited following ethics approval. Microdialysis fibres 
were implanted at a depth of 1mm at two separate sites on the volar aspect of the non-dominant 
forearm. The fibres were perfused with PBS (3µl/min) and each site randomly allocated to receive 
either non thermal low intensity US at a pulse ratio of 1:4 and an intensity of 0.5 W/cm2 and sham 
ultrasound (SUS) for 10 minutes. Dialysate was collected for 30 minutes prior to intervention and 
every 30 minutes following intervention and pro-inflammatory cytokines (IL-1ß, IL-6, IL-8, TNFα) 
quantified via immunoassay.    
Results: The mean (± SEM) baseline concentrations of IL-1ß, IL-6, IL-8 and TNFα were 0.9 (0.2), 3.5 
(0.8), 14.3 (4.1) and 0.3 (0.08) pg/ml. There was no significant difference in baseline values 
between the two sites. A significant (p<0.05) increase in all cytokines from baseline was observed 
following the application of sham US, with the mean (± SEM) concentrations of IL-1ß, IL-6, IL-8 and 
rising to 2.8 (0.5), 11.4 (1.6), 31.6 (3.6) and 0.8 (0.2) pg/ml. In contrast the increase seen in all 
cytokines, except TNFα, following HFUS was significantly (p<0.01) reduced, the mean (± SEM) IL-
1ß, IL-6, IL-8 and TNFα concentrations being 0.8 (0.1), 5.6 (0.7), 20.1 (2.3), and 0.4 (0.05) pg/ml 
(Figure 1). 
Discussion: This study demonstrates that US is able to modulate cytokine release in the superficial 
soft tissue and significantly reduces the release of proinflammatory cytokines compared to sham 
US.  
Clinical relevance: This suggests that current thinking concerning the mechanism of action of 
therapeutic US may need to be re-evaluated, and further studies are needed to explore the 
mechanisms involved and the potential benefits to the management of pressure ulcers. 
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